Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation

Endocrine

Volumn 44, Issue 2, 2013, Pages 496-503

  Binai, Nadine A ^a,c   Carra, Gert ^a   Löwer, Johannes ^a   Löwer, Roswitha ^a   Wessler, Silja ^b  

^a PAUL EHRLICH INSTITUT   (Germany)

^b UNIVERSITY OF SALZBURG   (Austria)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Breast cancer; Estrogen receptor; Leptin; Whole genome microarray

Indexed keywords

ESTROGEN RECEPTOR ALPHA; LEPTIN; STAT3 PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEPTIN; MICROARRAY ANALYSIS; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTOME; TUMOR CELLS, CULTURED;

EID: 84885609505     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9897-y     Document Type: Article

References (47)

1. G.L. Anderson, M.L. Neuhouser, Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev. Res. (Phila.) 5, 515-521 (2012)
2. A. Ray, M.P. Cleary, Obesity and breast cancer: a clinical biochemistry perspective. Clin. Biochem. 45, 189-197 (2012)
3. C. Garofalo, E. Surmacz, Leptin and cancer. J. Cell. Physiol. 207, 12-22 (2006)
4. C. Deglise, C. Bouchardy, M. Burri, M. Usel, I. Neyroud-Caspar, G. Vlastos, P.O. Chappuis, M. Ceschi, S. Ess, M. Castiglione, E. Rapiti, H.M. Verkooijen, Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Res. Treat. 120, 185-193 (2010)
5. B. Majed, A. Dozol, L. Ribassin-Majed, K. Senouci, B. Asselain, Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association. Breast Cancer Res. Treat. 126, 729-738 (2011)
6. G. Fruhbeck, Intracellular signalling pathways activated by leptin. Biochem. J. 393, 7-20 (2006)
7. K. Lang, J. Ratke, Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration. Cell Commun. Signal. 7, 27 (2009)
8. H. Feng, L. Zheng, Z. Feng, Y. Zhao, N. Zhang, The role of leptin in obesity and the potential for leptin replacement therapy. Endocrine (2012)
9. N. Ghilardi, S. Ziegler, A. Wiestner, R. Stoffel, M.H. Heim, R.C. Skoda, Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 93, 6231-6235 (1996)
10. C. Bjorbaek, S. Uotani, B. da Silva, J.S. Flier, Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 272, 32686-32695 (1997)
11. D. Cirillo, A.M. Rachiglio, R. la Montagna, A. Giordano, N. Normanno, Leptin signaling in breast cancer: an overview. J. Cell. Biochem. 105, 956-964 (2008)
12. N. Kiuchi, K. Nakajima, M. Ichiba, T. Fukada, M. Narimatsu, K. Mizuno, M. Hibi, T. Hirano, STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189, 63-73 (1999)
13. D. Sinibaldi, W. Wharton, J. Turkson, T. Bowman, W.J. Pledger, R. Jove, Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19, 5419-5427 (2000)
14. J.V. Alvarez, P.G. Febbo, S. Ramaswamy, M. Loda, A. Richardson, D.A. Frank, Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res. 65, 5054-5062 (2005)
15. L. Bjornstrom, M. Sjoberg, Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol. Endocrinol. 16, 2202-2214 (2002)
16. L. Canesi, C. Ciacci, M. Betti, L.C. Lorusso, B. Marchi, S. Burattini, E. Falcieri, G. Gallo, Rapid effects of 17beta-estradiol on cell signaling and function of Mytilus hemocytes. Gen. Comp. Endocrinol. 136, 58-71 (2004)
17. S. Catalano, L. Mauro, S. Marsico, C. Giordano, P. Rizza, V. Rago, D. Montanaro, M. Maggiolini, M.L. Panno, S. Ando, Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J. Biol. Chem. 279, 19908-19915 (2004)
18. P. Ciana, S. Ghisletti, P. Mussi, I. Eberini, E. Vegeto, A. Maggi, Estrogen receptor alpha, a molecular switch converting transforming growth factor-alpha-mediated proliferation into differentiation in neuroblastoma cells. J. Biol. Chem. 278, 31737-31744 (2003)
19. N.A. Binai, A. Damert, G. Carra, S. Steckelbroeck, J. Lower, R. Lower, S. Wessler, Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells. Int. J. Cancer 127, 55-66 (2010)
20. S. Wessler, C. Otto, N. Wilck, V. Stangl, K.H. Fritzemeier, Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity. J. Steroid Biochem. Mol. Biol. 98, 25-35 (2006)
21. L. Tora, A. Mullick, D. Metzger, M. Ponglikitmongkol, I. Park, P. Chambon, The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 8, 1981-1986 (1989)
22. R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, T.P. Speed, Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003)
23. J. Oliveros, VENNY. An interactive tool for comparing lists with Venn diagrams. http://bioinfogp.cnb.csic.es/tools/venny/. Accessed Aug 2012
24. T.D. Schmittgen, K.J. Livak, Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108 (2008)
25. K. Subik, J.F. Lee, L. Baxter, T. Strzepek, D. Costello, P. Crowley, L. Xing, M.C. Hung, T. Bonfiglio, D.G. Hicks, P. Tang, The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast cancer 4, 35-41 (2010)
26. R. Fusco, M. Galgani, C. Procaccini, R. Franco, G. Pirozzi, L. Fucci, P. Laccetti, G. Matarese, Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. Endocr. Relat. Cancer 17, 373-382 (2010)
27. C. Meazza, G. Vitale, S. Pagani, D. Castaldi, G. Ogliari, D. Mari, K. Laarej, C. Tinelli, M. Bozzola, Common adipokine features of neonates and centenarians. J. Pediatr. Endocrinol. Metab. 24, 953-957 (2011)
28. R. Ostan, L. Bucci, E. Cevenini, M. G. Palmas, E. Pini, M. Scurti, R. Vescovini, C. Caruso, D. Mari, G. Vitale, C. Franceschi, D. Monti, Metabolic syndrome in the offspring of centenarians: focus on prevalence, components, and adipokines. Age (2012). doi: 10.1007/s11357-012-9483-x
29. A. Ptak, E. Kolaczkowska, E. L. Gregoraszczuk, Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine (2012). doi: 10.1007/s12020-012-9788-7
30. P. Hekerman, J. Zeidler, S. Korfmacher, S. Bamberg-Lemper, H. Knobelspies, L. Zabeau, J. Tavernier, W. Becker, Leptin induces inflammation-related genes in RINm5F insulinoma cells. BMC Mol. Biol. 8, 41 (2007)
31. S. Loffreda, S.Q. Yang, H.Z. Lin, C.L. Karp, M.L. Brengman, D.J. Wang, A.S. Klein, G.B. Bulkley, C. Bao, P.W. Noble, M.D. Lane, A.M. Diehl, Leptin regulates proinflammatory immune responses. FASEB J. 12, 57-65 (1998)
32. D.J. Dauer, B. Ferraro, L. Song, B. Yu, L. Mora, R. Buettner, S. Enkemann, R. Jove, E.B. Haura, Stat3 regulates genes common to both wound healing and cancer. Oncogene 24, 3397-3408 (2005)
33. T. Jarde, F. Caldefie-Chezet, N. Goncalves-Mendes, F. Mishellany, C. Buechler, F. Penault-Llorca, M.P. Vasson, Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr. Relat. Cancer 16, 1197-1210 (2009)
34. C.N. Perera, H.G. Chin, N. Duru, I.G. Camarillo, Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. J. Endocrinol. 199, 221-233 (2008)
35. B. De Cat, G. David, Developmental roles of the glypicans. Semin. Cell Dev. Biol. 12, 117-125 (2001)
36. C. Zhang, S. Zhang, D. Zhang, Z. Zhang, Y. Xu, S. Liu, A lung cancer gene GPC5 could also be crucial in breast cancer. Mol. Genet. Metab. 103, 104-105 (2011)
37. P. Hulpiau, F. van Roy, Molecular evolution of the cadherin superfamily. Int. J. Biochem. Cell Biol. 41, 349-369 (2009)
38. M. Miyagawa, S.Y. Nishio, S. Usami, Prevalence and clinical features of hearing loss patients with CDH23 mutations: a large cohort study. PLoS ONE 7, e40366 (2012)
39. M. Apostolopoulou, L. Ligon, Cadherin-23 mediates heterotypic cell-cell adhesion between breast cancer epithelial cells and fibroblasts. PLoS ONE 7, e33289 (2012)
40. C.T. Dolphin, E.A. Shephard, S. Povey, R.L. Smith, I.R. Phillips, Cloning, primary sequence and chromosomal localization of human FMO2, a new member of the flavin-containing mono-oxygenase family. Biochem. J. 287, 261-267 (1992)
41. F. Fialka, R.M. Gruber, R. Hitt, L. Opitz, E. Brunner, H. Schliephake, F.J. Kramer, CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma - a pilot study. Oral Oncol. 44, 941-948 (2008)
42. S.K. Krueger, J.E. Vandyke, D.E. Williams, R.N. Hines, The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines. Drug Metab. Rev. 38, 139-147 (2006)
43. C. Mani, D. Kupfer, Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation. Cancer Res. 51, 6052-6058 (1991)
44. N.K. Verma, J. Dourlat, A.M. Davies, A. Long, W.Q. Liu, C. Garbay, D. Kelleher, Y. Volkov, STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. J. Biol. Chem. 284, 12349-12362 (2009)
45. J. Azare, K. Leslie, H. Al-Ahmadie, W. Gerald, P.H. Weinreb, S.M. Violette, J. Bromberg, Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. Mol. Cell. Biol. 27, 4444-4453 (2007)
46. D.C. Ng, B.H. Lin, C.P. Lim, G. Huang, T. Zhang, V. Poli, X. Cao, Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J. Cell Biol. 172, 245-257 (2006)
47. S.R. Walker, M. Chaudhury, D.A. Frank, STAT3 Inhibition by microtubule-targeted drugs: dual molecular effects of chemotherapeutic agents. Mol. Cell. Pharmacol. 3, 13-19 (2011)